Flow cytometry applications in pharmacodynamics and drug delivery

Pharmaceutical Research

Volumn 14, Issue 9, 1997, Pages 1106-1114

  Ramanathan, Murali ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antibodies; Anticancer agents; Cytokines; Fluorescence activated cell sorting; Fluorophore; Gene therapy; Immunosuppressants; Oligonucleotides

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; ANTIESTROGEN; ANTINEOPLASTIC AGENT; BROXURIDINE; CHLORPROMAZINE; CISPLATIN; CYCLOSPORIN; CYCLOSPORIN A; CYTOCHROME P450; CYTOKINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETHIDIUM BROMIDE; GENE PRODUCT; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MIFEPRISTONE; OKT 3; OLIGONUCLEOTIDE; PACLITAXEL; PROPIDIUM IODIDE; TAMOXIFEN; TOREMIFENE; UNINDEXED DRUG; VACCINE; VERAPAMIL;

CELL SELECTION; DIAGNOSTIC PROCEDURE; DRUG DEVELOPMENT; DRUG SCREENING; DRUG SYNTHESIS; FLOW CYTOMETRY; FLUORESCENCE; GENE THERAPY; HUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; FLOW CYTOMETRY; IMMUNOSUPPRESSIVE AGENTS;

EID: 0030751367     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012178001348     Document Type: Review

References (62)

1. J. V. Watson. Flow cytometry data analysis: basic concepts and statistics, Cambridge University Press, Cambridge, 1992.
2. R. J. Zagursky, D. Sharp, K. A. Solomon, and A. Schwartz. Quantitation of cellular receptors by a new immunocytochemical flow cytometry technique. Biotechniques 18:504-9 (1995).
3. B. L. Lokeshwar, S. M. Ferrell, and N. L. Block. Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy. Anticancer Research 15:93-8 (1995).
4. K. Kawamoto. Flow cytometric analysis of cell cycle for the action mechanism of antineoplastic agents. Human Cell 8:85-8 (1995).
5. S. K. Koester, J. U. Maenpaa, V. J. Wiebe, W. J. Baker, G. T. Wurz, R. C. Seymour, R. E. Koehler, and M. W. DeGregorio. Flow cytometry: potential utility in monitoring drug effects in breast cancer. [Review]. Breast Cancer Research & Treatment 32:57-65 (1994).
6. D. Campana, A. Manabe, and W. E. Evans. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 7:482-8 (1993).
7. W. G. Telford, L. E. King, and P. J. Fraker. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. [Review]. Journal of Immunological Methods 172:1-16 (1994).
8. G. Kroemer and C. Martinez. Pharmacological inhibition of programmed lymphocyte death [see comments]. Immunology Today 15:235-42 (1994).
9. A. H. Wyllie and R. G. Morris. Hormone-induced cell death. Purification ad properties of thymocytes undergoing apoptosis after glucocorticoid treatment. American Journal of Pathology 109:78-87 (1982).
10. A. H. Wyllie. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-6 (1980).
11. V. A. Fadok, D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. Journal of Immunology 148:2207-16 (1992).
12. G. Koopman, C. P. Reutelingsperger, G. A. Kuijten, R. M. Keehnen, S. T. Pals, and O. M. van. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-20 (1994).
13. I. Vermes, C. Haanen, N. H. Steffens, and C. Reutelingsperger. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods 184:39-51 (1995).
14. M. C. Needels, D. G. Jones, E. H. Tate, G. L. Heinkel, L. M. Kochersperger, W. J. Dower, R. W. Barrett, and M. A. Gallop. Generation and screening of an oligonucleotide-encoded synthetic peptide library. Proceedings of the National Academy of Sciences of the United States of America 90:10700-4 (1993).
15. K. Muller, F. O. Gombert, U. Manning, F. Grossmuller, P. Graff, H. Zaegel, J. F. Zuber, F. Freuler, C. Tschopp, and G. Baumann. Rapid identification of phosphopeptide ligands for SH2 domains. Screening of peptide libraries by fluorescence-activated bead sorting. Journal of Biological Chemistry 271:16500-5 (1996).
16. P. Midoux, R. Mayer, and M. Monsigny. Membrane permeabilization by alpha-helical peptides: a flow cytometry study. Biochimica et Biophysica Acta 1239:249-56 (1995).
17. D. W. Hedley and S. Chow. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry 15:349-58 (1994)
18. A. D. Miller. Flow cytometric techniques for measurement of cytochrome P-450 activity in viable cells. Methods in Cell Biology 33:71-9 (1990).
19. N. Testoni, G. Martinelli, P. Farabegoli, A. Zaccaria, M. Amabile, D. Raspadori, S. Pelliconi, E. Zuffa, C. Carboni, and S. Tura. A new method of "in-cell reverse transcriptase-polymerase chain reaction" for the detection of BCR/ABL transcript in chronic myeloid leukemia patients. Blood 87:3822-7 (1996).
20. B. K. Patterson, M. Till, P. Otto, C. Goolsby, M. R. Furtado, L. J. McBride, and S. M. Wolinsky. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260:976-9 (1993).
21. D. Gibellini, G. Zauli, M. C. Re, G. Furlini, S. Lolli, A. Bassini, C. Celeghini, and P. M. La. In situ polymerase chain reaction technique revealed by flow cytometry as a tool for gene detection. Analytical Biochemistry 228:252-8 (1995).
22. A. Krishan. Rapid determination of cellular resistance-related drug efflux in tumor cells. Methods in Cell Biology 33:491-500 (1990).
23. A. Krishan. Heterogeneity of anthracycline retention and response to efflux blockers in human tumors. Cytometry 21:72-5 (1995).
24. K. Nooter, P. Sonneveld, and A. Martens. Differences in the pharmacokinetics of daunomycin in normal and leukemic rats. Cancer Research 45:4020-5 (1985).
25. K. Nooter, H. Herweijer, R. Jonker, and G. van den Engh. On-line flow cytometry: a versatile method for kinetic measurements. Methods in Cell Biology 33:631-45 (1990).
26. J. P. Nolan, R. G. Posner, J. C. Martin, R. Habbersett, and L. A. Sklar. A rapid mix flow cytometer with subsecond kinetic resolution. Cytometry 21:223-9 (1995).
27. M. S. Dordal, A. C. Ho, S. M. Jackson, Y. F. Fu, C. L. Goolsby, and J. N. Winter. Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs. Cytometry 20:307-14 (1995).
28. V. L. Lim, M. Gumbert, and M. R. Garovoy. A flow cytometric method for the detection of the development of antibody to Orthoclone OKT3. Journal of Immunological Methods 121:197-201 (1989).
29. N. Cohen, M. Gumbert, J. Birnbaum, V. L. Lim, D. Falco, N. Ascher, J. Roberts, and M. R. Garovoy. An improved method for the detection of soluble interleukin 2 receptors in liver transplant recipients by flow cytometry. Transplantation 51:417-21 (1991).
30. T. M. McHugh. Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes. Methods in Cell Biology (1994).
31. W. Piekoszewski, F. S. Chow, and W. J. Jusko. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits. Journal of Pharmacology & Experimental Therapeutics 269:103-9 (1994).
32. E. V. Mishina and W. J. Jusko. Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation. Pharmaceutical Research 11:848-54 (1994).
33. U. Junge, J. Hoekstra, L. Wolfe, and F. Deinhardt. Microtechnique for quantitative evaluation of in vitro lymphocyte transformation. Clinical & Experimental Immunology 7:431-7 (1970).
34. H. Gaines, L. Andersson, and G. Biberfeld. A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry. Journal of Immunological Methods 195:63-72 (1996).
35. V. C. Maino, M. A. Suni, and J. J. Ruitenberg. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 20:127-33 (1995).
36. R. Testi, J. H. Phillips, and L. L. Lanier. T cell activation via Leu-23 (CD69). Journal of Immunology 143:1123-8 (1989).
37. P. E. Simms and T. M. Ellis. Utility of flow cytometric detection of CD69 expression as a rapid method for determining polyand oligoclonal lymphocyte activation. Clinical & Diagnostic Laboratory Immunology 3:301-4 (1996).
38. A. Caruso, S. Licenziati, M. Corulli, A. D. Canaris, M. A. De Francesco, S. Fiorentini, L. Peroni, F. Fallacara, F. Dima, A. Balsari, and A. Turano. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 27:71-6 (1997).
39. J. Andersson, S. Nagy, C. G. Groth, and U. Andersson. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 75:136-42 (1992).
40. M. F. Powell. Drug delivery issues in vaccine development [Review]. Pharmaceutical Research 13:1777-1785 (1996).
41. F. Powrie and R. L. Coffman. Cytokine regulation of T-cell function: potential for therapeutic intervention. Trends in Pharmacological Sciences. 14:164-8 (1993).
42. U. Schauer, T. Jung, N. Krug, and A. Frew. Measurement Of Intracellular Cytokines. Immunology Today 17:305-306 (1996).
43. C. Prussin and D. D. Metcalfe. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. Journal of Immunological Methods 188:117-28 (1995).
44. U. Andersson, G. Hallden, U. Persson, J. Hed, G. Moller, and M. DeLey. Enumeration of IFN-gamma-producing cells by flow cytometry. Comparison with fluorescence microscopy. Journal of Immunological Methods 112:139-42 (1988).
45. M. A. Goodell, K. Brose, G. Paradis, A. S. Conner, and R. C. Mulligan. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Journal of Experimental Medicine 183:1797-806 (1996).
46. N. S. Wolf, A. Kone, G. V. Priestley, and S. H. Bartelmez. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Experimental Hematology 21:614-22 (1993).
47. T. Leemhuis, M. C. Yoder, S. Grigsby, B. Aguero, P. Eder, and E. F. Srour. Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123. Experimental Hematology 24:1215-24 (1996).
48. M. Chalfie, Y. Tu, G. Euskirchen, W. W. Ward, and D. C. Prasher. Green fluorescent protein as a marker for gene expression. Science 263:802-5 (1994).
49. J. D. Ropp, C. J. Donahue, K. D. Wolfgang, J. J. Hooley, J. Y. Chin, R. A. Hoffman, R. A. Cuthbertson, and K. D. Bauer. Aequorea green fluorescent protein analysis by flow cytometry. Cytometry 21:309-17 (1995).
50. R. Heim, D. C. Prasher, and R. Y. Tsien. Wavelength mutations and posttranslational autoxidation of green fluorescent protein. Proceedings of the National Academy of Sciences of the United States of America 91:12501-4 (1994).
51. A. B. Cubitt, R. Heim, S. R. Adams, A. E. Boyd, L. A. Gross, and R. Y. Tsien. Understanding, improving and using green fluorescent proteins. [Review]. Trends in Biochemical Sciences 20:448-55 (1995).
52. R. Heim, A. B. Cubitt, and R. Y. Tsien. Improved green fluorescence [letter]. Nature 373:663-4 (1995).
53. B. P. Cormack, R. H. Valdivia, and S. Falkow. FACS-optimized mutants of the green fluorescent protein (GFP). Gene 173:33-8 (1996).
54. A. M. Gewirtz, C. A. Stein, and P. M. Glazer. Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proceedings of the National Academy of Sciences of the United States of America 93:3161-3 (1996).
55. J. G. Lewis, K. Y. Lin, A. Kothavale, W. M. Flanagan, M. D. Matteucci, R. B. DePrince, R. A. Mook, Jr., R. W. Hendren, and R. W. Wagner. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proceedings of the National Academy of Sciences of the United States of America 93:3176-81 (1996).
56. J. L. Tonkinson and C. A. Stein. Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Research 22:4268-75 (1994).
57. C. A. Stein, J. L. Tonkinson, L. M. Zhang, L. Yakubov, J. Gervasoni, R. Taub, and S. A. Rotenberg. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32:4855-61 (1993).
58. Q. Zhao, X. Song, T. Waldschmidt, E. Fisher, and A. M. Krieg. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation. Blood 88:1788-95 (1996).
59. A. M. Krieg, M. F. Gmelig, M. F. Gourley, W. J. Kisch, L. A. Chrisey, and A. D. Steinberg. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible. Antisense Research & Development 1:161-71 (1991).
60. Q. Zhao, T. Waldschmidt, E. Fisher, C. J. Herrera, and A. M. Krieg. Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors. Blood 84:3660-6 (1994).
61. R. E. Durand. Calibration of flow cytometer detector systems. Methods in Cell Biology 42:597-604 (1994).
62. M. Ramanathan and M. R. Garovoy. Flow cytometry. In N. Tilney, T. B. Strom, and L. C. Paul (eds.), Transplantation biology: molecular and cellular aspects. Lippincott-Raven, New York, 1966 pp. 57-71.